Independent provider comparison
Updated October 1, 2026
MEDVi vs SnagRx: Which GLP-1 provider is better?
A side-by-side look at total cost, medication format, care, commitment and the situations where each option makes more sense.
The decision
Which should you choose, MEDVi or SnagRx?
Short answer: MEDVi scores higher on our published rubric, 5.7/10 against 4.5/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; SnagRx is published $99/mo; total not verified.
Consider MEDVi if
Users who want both oral and injectable compounded options in one telehealth program.
Consider SnagRx if
Cash-pay buyers who want a published injectable-plan price grid and will compare monthly billing with prepaid terms before checkout.
Scores follow our published methodology. Partnership status does not change the score or the factual comparison.
Cost
First charge, renewal and commitment
Treatment
Medication, form and approval status
Care
Clinical review and ongoing support
Terms
Cancellation and material cautions
MEDVi
#25 of 36Best for users who want both oral and injectable compounded options in one telehealth program.
Visit MEDVi
SnagRx
#33 of 36Best for cash-pay buyers who want a published injectable-plan price grid and will compare monthly billing with prepaid terms before checkout.
Visit SnagRxSide by side
MEDVi vs SnagRx at a glance
Compare the price unit as well as the number. A medication-only price, prepaid monthly equivalent and complete recurring program are not the same thing.
| Feature | MEDVi | SnagRx |
|---|---|---|
| Our Score | 5.7/10 | 4.5/10 |
| Headline Price | $179 first month, then $299/mo | published $99/mo; total not verified |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want both oral and injectable compounded options in one telehealth program | Cash-pay buyers who want a published injectable-plan price grid and will compare monthly billing with prepaid terms before checkout |
| Watch out for | FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication | A small independent review sample: Trustpilot showed 3.1/5 from 7 reviews on October 1, 2026. It cannot establish a typical experience or corroborate the homepage's customer-count claim |
| Ranking | #25 | #33 |
| Get started | Visit MEDVi | Visit SnagRx |
Trade-offs
Strengths and cautions compared
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +The landing page says the program is HSA and FSA eligible and includes dietician visits and care coaching, with a footnote making that subject to insurance and copay eligibility
- +Sleek onboarding experience with clear progress tracking through their patient portal
1 more documented strengths
- +$179 covers the first month of compounded semaglutide on MEDVi's landing page, including physician review, the personalized plan, medication and free shipping
Cons
- −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
- −Its third-party records conflict: 4.3 out of 5 across 14,680 Trustpilot reviews with 12 percent of them at one star, against an F and no accreditation at the BBB
- −The $179 semaglutide price covers month one only; the FAQ on MEDVi's own landing page says refills are locked in at $299 a month, making the first year $3,468 rather than $2,148
2 more documented cautions
- −Brand-name Wegovy and Zepbound paths add a $99 membership plus a medication cost the page does not publish, and the same page's hero says "No membership or hidden fees!" directly above those cards; availability is subject to change
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
SnagRx
Pros
- +A public plan grid: semaglutide at $99, $89, $79 and $69/mo across one, three, six and twelve months, and tirzepatide at $149, $139, $129 and $119. Longer terms are paid upfront
- +Names four partner pharmacies in its footer with full street addresses and phone numbers, Red Rock Compounding, Health Warehouse, Precision Medicine and Triad Rx, which most competitors do not do
- +Evaluation, prescribed medication, support and shipping are advertised as included; the stated 1-2 day shipping is an estimate, not a guarantee
2 more documented strengths
- +Monthly billing is available alongside prepaid discounts, with a separate published refund policy and no advertised monthly membership fee
- +States service in all 50 states plus Washington D.C. in its terms, and names the two carve-outs on the homepage: no service in Louisiana, and Nebraska limited to patients 19 and over
Cons
- −A small independent review sample: Trustpilot showed 3.1/5 from 7 reviews on October 1, 2026. It cannot establish a typical experience or corroborate the homepage's customer-count claim
- −The homepage leads the 12-month rate ($69/mo, billed $828 once) under a countdown timer that re-seeds on each visit instead of counting down to a dated deadline, while the month-to-month rate is $99
- −Cancellation normally stops future renewal without refunding the prepaid term. The terms say to cancel at least 5 days before the period ends; the refund policy says 72 hours before billing. Confirm the cutoff and keep written confirmation
5 more documented cautions
- −The product pages advertise included evaluation, but the terms allow the charge to vary by medication or pharmacy. A non-refundable consultation clause does not prove an extra mandatory fee; confirm your total before payment
- −Payment is final and non-refundable at the moment of purchase, before a clinician has read your intake, and multi-month plans are sold as a single indivisible purchase that is non-refundable in whole and in part. The one exception is a provider ruling you medically ineligible, and even then the value of services already rendered is deducted
- −No individual clinician is named. SnagRx says in a homepage FAQ that it has a medical director who is a practising physician, and its footer names OpenLoop Health as the treating network, but no provider name, licence number, lab requirement or video-visit detail is published
- −Shares its operating entity with Embody and RodeoMeds. Neither SnagRx nor Embody discloses the relationship on its own site, so a shopper comparing them would not know they are one company
- −Cash-pay only, no insurance billing and no prior-authorisation help
Our Verdict
MEDVi edges out SnagRx with a score of 5.7/10 vs 4.5/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; SnagRx is published $99/mo; total not verified. MEDVi offers both brand-name and compounded medications, giving you more flexibility.
Keep narrowing the decision
What should you compare next?
Use the unresolved part of this choice, not a generic related article. These guides own the broader medication, coverage or complete-cost question.
- Pill decisionCompare Wegovy pill prices and accessUse the dedicated guide for dose-specific costs, required memberships and which providers currently list the FDA-approved pill.Continue
- Cost decisionCompare complete recurring program costsSee which prices include medication, clinical care and shipping, and which headline amounts require another fee or commitment.Continue
- Treatment decisionCompare semaglutide providers and pricesMove from this head-to-head to the broader semaglutide market without confusing compounded products with FDA-approved brands.Continue
Reviews and pricing sources
Related comparisons
More head-to-head comparisons involving MEDVi and SnagRx.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare MEDVi and Luvo Healthfrom $249/4 weeks
- Compare MEDVi and Breeze Medsfrom $199/mo
- Compare MEDVi and Willowfrom $299/mo
- Compare SnagRx and HealthRXfrom $99/mo
- Compare SnagRx and Collectivefrom $59/mo + $199/year membership after 21 days
- Compare SnagRx and Enhance MDfrom $212/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is MEDVi legit and is SnagRx legit, with the verification evidence behind each answer.
Our pick of these two: MEDVi · 5.7/10